Monday, April 13, 2009

Express Scripts to Buy WellPoint's NextRx

We live in a day of M&As (mergers and acquisitions) in the healthcare industry. Pfizer is buying Wyeth, but that's old news. Why should pharma have all the fun?

Express Scripts is buying WellPoint's NextRx for $4.7 billion. Actually, maybe that's $4.68. In either case, it's a huge amount of money. So who's next? According to Express Scripts, NextRx manages prescription benefits for about 25 million customers and handles more than 265 million prescriptions a year.

No comments:

Post a Comment